Serum Institute of India's CEO Adar Poonawalla on Thursday, 19 November, announced that the country could receive the Oxford COVID-19 vaccine for the frontline healthcare workers by the year 2020 or early next year.
{{nQcAwYhXHrXXKWKSsdAL}}
It is likely to be priced at a maximum of Rs 500-600, he said.
More In :
Serum Institute of India is planning to produce 100 million dosages of vaccines by February 2021.
Meanwhile, COVID-19 cases in India have crossed 9 million mark. A total of 9,004,365 people have so far tested positive for the dreaded virus, with 4,43,794 cases currently being active. The novel coronavirus has taken the lives of 1,32,162 persons in India.